Indraprastha Selling And Marketing Expenses from 2010 to 2024
| INDRAMEDCO | 459.75 22.90 5.24% |
Selling And Marketing Expenses | First Reported 2010-12-31 | Previous Quarter 1 B | Current Value 528.7 M | Quarterly Volatility 229 M |
Check Indraprastha Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Indraprastha Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 300.3 M, Interest Expense of 35.6 M or Selling General Administrative of 111.6 M, as well as many indicators such as . Indraprastha financial statements analysis is a perfect complement when working with Indraprastha Medical Valuation or Volatility modules.
Indraprastha | Selling And Marketing Expenses |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Indraprastha Stock
Indraprastha Medical financial ratios help investors to determine whether Indraprastha Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Indraprastha with respect to the benefits of owning Indraprastha Medical security.